Reversible regulation of the retinoblastoma protein/E2F-1 pathway during "reverse cardiac remodelling" after ventricular unloading

Journal of Heart and Lung Transplantation

Volumn 29, Issue 1, 2010, Pages 117-124

  Wohlschlaeger, Jeremias ^a   Schmitz, Klaus Jürgen ^a   Takeda, Atsushi ^b   Takeda, Nobuakira ^c   Vahlhaus, Christian ^d   Stypmann, Jörg ^d   Schmid, Christof ^d   Baba, Hideo Andreas ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

^b GUNMA PAZ UNIVERSITY   (Japan)

^c JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

cardiac hypertrophy; congestive heart failure; LVAD; pocket proteins; retinoblastoma protein

Indexed keywords

CYCLIN D1; CYCLIN DEPENDENT KINASE 4; PROTEIN P107; PROTEIN P130; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

ADOLESCENT; ADULT; ARTICLE; CELL STRUCTURE; CHILD; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; FEMALE; HEART MUSCLE; HEART MUSCLE CELL; HEART VENTRICLE FUNCTION; HEART VENTRICLE HYPERTROPHY; HEART VENTRICLE REMODELING; HEART VENTRICLE UNLOADING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MORPHOMETRICS; PATHOGENESIS; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; QUANTITATIVE ANALYSIS; SCHOOL CHILD; SIGNAL TRANSDUCTION;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; CRK-ASSOCIATED SUBSTRATE PROTEIN; CYCLIN D1; E2F1 TRANSCRIPTION FACTOR; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART-ASSIST DEVICES; HUMANS; HYPERTROPHY; MALE; MIDDLE AGED; MYOCYTES, CARDIAC; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; RETROSPECTIVE STUDIES; SIGNAL TRANSDUCTION; VENTRICULAR REMODELING; YOUNG ADULT;

EID: 72249123143     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2009.09.017     Document Type: Article

References (24)

1. Dorn G.W., and Force T. Protein kinase cascades in the regulation of cardiac hypertrophy. J Clin Invest 115 (2005) 527-537
2. Nozato T., Ito H., Tamamori M., et al. G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II. Jpn Circ J 64 (2000) 595-601
3. Busk P.K., and Hinrichsen R. Cyclin D in left ventricle hypertrophy. Cell Cycle 2 (2003) 91-95
4. Johnson D.G., and Schneider-Broussard R. Role of E2F in cell cycle control and cancer. Front Biosci 3 (1998) d447-d448
5. Hinds P.W., Mittnacht S., Dulic V., Arnold A., Reed S.I., and Weinberg R.A. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70 (1992) 993-1006
6. Trimarchi J.M., and Lees J.A. Sibling rivalry in the E2F family. Nat Rev Mol Cell Biol 3 (2002) 11-20
7. von Harsdorf R., Hauck L., Mehrhof F., Wegenka U., Cardoso M.C., and Dietz R. E2F-1 overexpression in cardiomyocytes induces downregulation of p21CIP1 and p27KIP1 and release of active cyclin-dependent kinases in the presence of insulin-like growth factor I. Circ Res 85 (1999) 128-136
8. Vara D., Bicknell K.A., Coxon C.H., and Brooks G. Inhibition of E2F abrogates the development of cardiac myocyte hypertrophy. J Biol Chem 278 (2003) 21388-21394
9. Frazier O.H., Benedict C.R., Radovancevic B., et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg 62 (1996) 675-681
10. Levin H.R., Oz M.C., Chen J.M., Packer M., Rose E.A., and Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation 91 (1995) 2717-2720
11. Nakatani S., McCarthy P.M., Kottke-Marchant K., et al. Left ventricular echocardiographic and histologic changes: impact of chronic unloading by an implantable ventricular assist device. J Am Coll Cardiol 27 (1996) 894-901
12. Baba H.A., Grabellus F., August C., et al. Reversal of metallothionein expression is different throughout the human myocardium after prolonged left-ventricular mechanical support. J Heart Lung Transplant 19 (2000) 668-674
13. Gundersen H.J.G. Notes on the estimation of the numerical density of arbitrary profiles: the edge effect. Acta Derm Venereol 57 (1977) 173-176
14. Zafeiridis A., Jeevanandam V., Houser S.R., and Margulies K.B. Regression of cellular hypertrophy after left ventricular assist device support. Circulation 98 (1998) 656-662
15. Nozato T., Ito H., Tamamori M., et al. G1 cyclins are involved in the mechanism of cardiac myocyte hypertrophy induced by angiotensin II. Jpn Circ J 64 (2000) 595-601
16. Busk P.K., Bartkova J., Strom C.C., et al. Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro. Cardiovasc Res 56 (2002) 64-75
17. Ecarnot-Laubriet A., Assem M., Poirson-Bichat F., et al. Stage-dependent activation of cell cycle and apoptosis mechanisms in the right ventricle by pressure overload. Biochim Biophys Acta 1586 (2002) 233-242
18. Giacinti C., and Giordano A. RB and cell cycle progression. Oncogene 25 (2006) 5220-5227
19. Cobrinik D., Dowdy S.F., Hinds P.W., Mittnacht S., and Weinberg R.A. The retinoblastoma protein and the regulation of cell cycling. Trends Biochem Sci 17 (1992) 312-315
20. Cobrinik D. Pocket proteins and cell cycle control. Oncogene 24 (2005) 2796-2809
21. Zorc M., Vraspir-Porenta O., Zorc-Pleskovic R., Radovanovic N., and Petrovic D. Apoptosis of myocytes and proliferation markers as prognostic factors in end-stage dilated cardiomyopathy. Cardiovasc Pathol 12 (2003) 36-39
22. Liu Y., Cigola E., Cheng W., et al. Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest 73 (1995) 771-787
23. Kanoh M., Takemura G., Misao J., et al. Significance of myocytes with positive DNA in situ nick end-labeling (TUNEL) in hearts with dilated cardiomyopathy: not apoptosis but DNA repair. Circulation 99 (1999) 2757-2764
24. Yurkova N., Shaw J., Blackie K., et al. The cell cycle factor E2F-1 activates Bnip3 and the intrinsic death pathway in ventricular myocytes. Circ Res 102 (2008) 472-479